Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-12

FDA Approved: LEVETIRACETAM IN SODIUM CHLORIDE — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved Hikma Pharmaceuticals USA Inc.'s generic levetiracetam in sodium chloride injection under an Original Application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levetiracetam in Sodium Chloride (LEVETIRACETAM IN SODIUM CHLORIDE)

Snippet

ORIG AP for LEVETIRACETAM IN SODIUM CHLORIDE (LEVETIRACETAM IN SODIUM CHLORIDE)